Carcinogenicity of combined oestrogen-progestag... [Lancet Oncol. 2005] - PubMed

Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer. [Lancet Oncol. 2005]
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro S. Lancet Oncol. 2005 Oct; 6(10):736; author reply 737.
Oestroprogestagens and severe acute pyelonephritis: a casual or causal association? [Nephrol Dial Transplant. 2006]
Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
Piccoli GB, Colla L, Mezza E, Burdese M, Cammarota T, Piccoli G. Nephrol Dial Transplant. 2006 Aug; 21(8):2337.
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer. [Lancet Oncol. 2005]
Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Szarewski A. Lancet Oncol. 2005 Oct; 6(10):736-7; author reply 737.
Review Hormone replacement therapy and the risk of breast cancer. [Eur J Cancer. 2008]
Review Hormone replacement therapy and the risk of breast cancer.
Cuzick J. Eur J Cancer. 2008 Nov; 44(16):2344-9. Epub 2008 Sep 8.
Review Hormones and cardiovascular health in women. [Hum Reprod Update. 2006]
Review Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group. Hum Reprod Update. 2006 Sep-Oct; 12(5):483-97. Epub 2006 Jun 28.

Human papillomavirus in upper digestive tract tumors from three countries. [World J Gastroenterol. 2011]
Human papillomavirus in upper digestive tract tumors from three countries.
Castillo A, Koriyama C, Higashi M, Anwar M, Bukhari MH, Carrascal E, Mancilla L, Okumura H, Matsumoto M, Sugihara K, et al. World J Gastroenterol. 2011 Dec 28; 17(48):5295-304.
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma. [Clin Med Insights Oncol. 2011]
The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.
Efird JT, Toland AE, Lea CS, Phillips CJ. Clin Med Insights Oncol. 2011 Mar 27; 5:55-75. Epub 2011 Mar 27.
Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse. [Dtsch Arztebl Int. 2008]
Decline in hormone replacement prescription and fall in breast cancer incidence: an epidemiological discourse.
Stang A. Dtsch Arztebl Int. 2008 Apr; 105(16):303-9. Epub 2008 Apr 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal ...
Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
Lancet Oncol. 2005 Aug ;6(8):552-3.

PubMed
Distinct organ-specific metastatic potential of individual breast cancer cells a...
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
J Clin Invest. 2005 Jan ;115(1):44-55.

PubMed
Diet and breast cancer: a review of the prospective observational studies.
Diet and breast cancer: a review of the prospective observational studies.
Cancer. 2007 Jun 15 ;109(12 Suppl):2712-49.

PubMed
Imaging mass spectrometry: principles and potentials.
Imaging mass spectrometry: principles and potentials.
Toxicol Pathol. 2005 ;33(1):92-101.

PubMed
Comparison of fluorescence and chromogenic in situ hybridization for detection o...
Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer.
Am J Clin Pathol. 2003 Mar ;119(3):381-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed